Page 130 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Liver Transplantation / Surgery: Clinical (Cont.)

YI P0063 SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT
OF SEVERE HCV RECURRENCE AFTER LIVER
TRANSPLANTATION: PRELIMINARY DATA FROM
A SINGLE-CENTRE EXPERIENCE
Sacco Marco*, Silvia Martini, Silvia Strona, Daniele Arese,
Donatella Cocchis, Stefano Mirabella, Giorgia Rizza, Francesco Tandoi,
Renato Romagnoli, Antonio Ottobrelli, Maria Rosaria Torrani Cerenzia,
Federico Balzola, Mauro Salizzoni, Mario Rizzetto, Italy

YI P0064 RIBAVIRIN PRE-TREATMENT IN LIVER TRANSPLANT
PATIENTS WITH HCV RECURRENCE: RESULTS FROM
PEARL MULTICENTRE RANDOMIZED TRIAL
Valerio Giannelli*, Alberto Zanetto, Patrizia Burra, Ponziani R. Francesca,
Antonio Gasbarrini, Ubaldo V. Comandini, Giuseppe M. Ettorre,
Michela Giusto, Elisa Biliotti, Manuela Merli, Gloria Taliani, Italy

YI P0065 EFFECT OF PORTAL VEIN THROMBOSIS (PVT) ON
SURVIVAL AFTER LIVER TRANSPLANTATION (LT):
ePOSTERS A METANALYSIS
Alberto Zanetto*, Kryssia-Isabel Rodriguez-Castro, Elena Nadal,
Alberto Ferrarese, Giacomo Germani, Francesco P. Russo, Patrizia Burra,
Marco Senzolo, Italy

YI P0066 DIASTOLIC DYSFUNCTION IS PROGNOSTIC FOR
MORTALITY IN LIVER TRANSPLANTED PATIENTS WITH
NORMAL EJECTION FRACTION
Thoetchai Peeraphatdit, Niyada Naksuk*, Charat Thongprayoon,
Parkpoom Phatharacharukul, Chayakrit Krittanawong, Paola Ricci,
Roongruedee Chaiteerakij, Kyle Klarich, Lewis R. Roberts,
The United States

YI P0067 HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH
LOWER SURVIVAL FOLLOWING LIVING DONOR LIVER
TRANSPLANTATION IN THE U.S
Ryan B. Perumpail*, Andy Liu, Randy Liang, David T. Chao,
Sammy Saab, Zobair M. Younossi, Robert J. Wong, Aijaz Ahmed,
Waldo Concepcion, Carlos O. Esquivel, Clark A. Bonham,
The United States

130 The International Liver Congress™ 2015 • ILC Programme